Pages that link to "Q72725593"
Jump to navigation
Jump to search
The following pages link to Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg) (Q72725593):
Displaying 10 items.
- Simultaneous measurements of auto-immune and infectious disease specific antibodies using a high throughput multiplexing tool (Q34404786) (← links)
- Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review. (Q35089149) (← links)
- Immunomodulation and remyelination: two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies? (Q41589704) (← links)
- Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism (Q42604240) (← links)
- Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy (Q43533051) (← links)
- Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy (Q50969853) (← links)
- Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy (Q70872840) (← links)
- Normal human plasma contains antibodies that specifically block neuropathy-associated human anti-GM1 IgG-antibodies (Q73608375) (← links)
- Association of IgM type anti‐GM1 antibodies and muscle strength in chronic acquired demylelinating polyneuropathy (Q74122051) (← links)
- A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy (Q81379967) (← links)